Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
3.280
+0.260 (8.61%)
At close: Oct 2, 2026, 4:00 PM EDT
3.140
-0.140 (-4.27%)
After-hours: Oct 2, 2026, 7:54 PM EDT

Basel Medical Group Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22
533---
Market Cap Growth
-84.82%----
Enterprise Value
629---
Last Close Price
3.0221.36---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.413.75---
PB Ratio
0.977.83---
P/TBV Ratio
0.977.84---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
0.513.30---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
1.511.200.761.312.74
Debt / EBITDA Ratio
--2.102.823.34
Debt / FCF Ratio
--2.282.783.76
Net Debt / Equity Ratio
0.22-0.600.491.082.29
Net Debt / EBITDA Ratio
-0.351.621.652.903.42
Net Debt / FCF Ratio
-0.110.221.472.273.14
Asset Turnover
0.840.650.630.61-
Inventory Turnover
58.6531.9070.6667.92-
Quick Ratio
1.811.220.550.630.63
Current Ratio
1.891.312.262.282.18
Return on Equity (ROE)
-147.37%-163.64%31.77%38.79%-
Return on Assets (ROA)
-15.46%-7.65%8.66%7.77%-
Return on Invested Capital (ROIC)
-54.56%-32.00%16.73%14.21%16.72%
Return on Capital Employed (ROCE)
-34.40%-25.10%24.00%22.50%25.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-165.16%-24.98%---
FCF Yield
-213.17%-35.09%---
Buyback Yield / Dilution
-23.41%-15.60%---
SEC Filings: 10-K · 10-Q